Vanberra Signal

FastDetect

Curated by Signal

Developer of smart testing devices for infectious disease detection

Overview

FastDetect is a developer of smart testing devices for infectious disease detection. It has developed a coronavirus testing devices with qPCR patented solenoid-based thermal cycling technology. It uses HIPAA compliant & offers communication and data storage. The product FastDetect FD-1 is a testing and diagnostic instrument utilizing the RT-PCR technique to identify pathogens and report on infections. It provides reports on the molecular testing genetic material of pathogens like the SARS-CoV-2 coronavirus. It also offers FastDetect FD-1 software solutions that help to controls the operations of the instrument as well as stores and communicates the test answer back to the appropriate parties. It controls the rapid thermocycling process necessary for the RT-PCR.

Key facts

Founded
2003

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Omics platform for storing, analyzing, and understanding life sciences data to accelerate scientific discovery

    Life Sciences TechnologyAustin, United States
  • Developer of cervical cancer screening device

    Life Sciences TechnologyMcallen, United States

About FastDetect

What does FastDetect do?

FastDetect is a developer of smart testing devices for infectious disease detection.

Where is FastDetect headquartered?

FastDetect is headquartered in Pasadena, United States.

When was FastDetect founded?

FastDetect was founded in 2003.

Which sector is FastDetect in?

FastDetect operates in Life Sciences Technology.

Who are FastDetect's competitors?

Companies similar to FastDetect include GenRAIT, Neural Dynamics Technologies, and Hera Diagnostics.